Effect of Exercise on ADMA Level in Type 2 Diabetes Mellitus

Objective: The increase in symmetric (SDMA) and asymmetric dimethyl arginine (ADMA) is associated with endothelial dysfunction. The aim of this study was to evaluate the effect of exercise on ADMA and SDMA levels and related ratios in type 2 DM. Material and Methods: Thirty-six women with type 2 DM and 44 healthy women were recruited to the study. Fourteen and 19 subjects, respectively, attended four-weeks of moderate intensity exercise. Plasma SDMA, ADMA, and L-arginine levels were measured by the HPLC method initially, after the first exercise session, and after one month. Results: All measurements were within the normal range in both groups and did not change significantly immediately after exercise and after the first month. In the healthy group, L-arginine/ADMA and L-arginine/SDMA ratios after one month were significantly higher than the initial values (palt;0.022 and p=0.017, respectively). After one month of exercise, L-arginine/ADMA and L-arginine/SDMA ratios increased in diabetics and decreased in healthy subjects when compared to those after the first exercise session (p=0.026 and p=0.037, respectively). Conclusion: We suggest that L-arginine/ADMA and L-arginine/SDMA ratios should be used in spite of absolute values. These molecules have a substantial role in the beneficial effects of exercise in healthy subjects while their role is small in diabetics. Turkish Baslik: Tip 2 Diabetes Mellitusta Egzersizin Adma Duzeyine Etkisi Anahtar Kelimeler: ADMA, arginin, egzersiz, diabetes mellitus tip 2 Amac: Simetri (SDMA) ve asimetri dimetil argininde (ADMA)artis endotelyal disfonksiyona isaret eder. Bu projenini amaci tip 2 diabetes mellitusta egzersizden sonraki duzeylerini incelemektir. Hastalar ve Yontemler: Tip 2 DM bulunan 36 kadin ve 44 saglikli kadin dahil edildi. Sirasiyla 14 ve 19a#39;u 4 haftalik orta yogunlukta egzersize alindi. Baslangicta, ilk egzersiz seansindan sonra ve bir ay sonra plazmada SDMA, ADMA ve L-arginin duzeyleri HPLC yontemiyle olculdu. Bulgular: Her iki grupta da tum olcumler normal araliktaydi ve ne egzersizden sonra ne de bir ayin sonunda belirgin olarak degismedi. Egzersiz yapan saglikli grupta bir ayin sonunda L-arginin/ADMA ve L-arginin/SDMA oranlari baslangic degerlerine gore belirgin olarak yuksek bulundu (sirasiyla, palt;0.022 ve 0.017). Bir aylik egzersizin sonunda, ilk egzersiz seansi sonundaki degerlere gore oranlar diyabetiklerde artti ve saglikli kisilerde azaldi. Sonuc: Mutlak degerlerden ziyade L-arginin/ADMA ve L-arginin/SDMA oranlarinin kullanilmasi gerektigini dusunuyoruz. Saglikli kisilerde egzersizin yararli etkileri acisindan bu molekullerin onemli rolu bulunurken diyabetiklerde bu rol cok azdir.

[1]  I. Komuro,et al.  Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus. , 2009, International journal of cardiology.

[2]  J. Tanus-Santos,et al.  Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. , 2008, Nitric oxide : biology and chemistry.

[3]  S. Yamagishi,et al.  Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications. , 2008, Current pharmaceutical design.

[4]  K. Doi,et al.  Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. , 2008, Diabetes research and clinical practice.

[5]  Nezih Hekim,et al.  Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus. , 2007, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[6]  L. Ignarro,et al.  The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. , 2007, Pharmacology & therapeutics.

[7]  S. Ueno,et al.  Asymmetric dimethylarginine (ADMA) in the aqueous humor of diabetic patients. , 2007, Endocrine journal.

[8]  M. Wolzt,et al.  Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[9]  Nutrition Recommendations and Interventions for Diabetes , 2007, Diabetes Care.

[10]  K. Kawecka-Jaszcz,et al.  Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance. , 2007, Metabolism: clinical and experimental.

[11]  S. Yamagishi,et al.  A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes. , 2007, Medical hypotheses.

[12]  A. Auteri,et al.  Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease. , 2006, Prostaglandins & other lipid mediators.

[13]  S. Yasuda,et al.  Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase. , 2006, European heart journal.

[14]  G. Breithardt,et al.  Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. , 2006, Journal of the American Society of Nephrology : JASN.

[15]  M. Wolzt,et al.  Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus , 2005, Wiener klinische Wochenschrift.

[16]  R. Böger Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials , 2005 .

[17]  A. Coats,et al.  Home‐based exercise training modulates pro‐oxidant substrates in patients with chronic heart failure , 2005, European journal of heart failure.

[18]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[19]  F. Schweitzer,et al.  Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[20]  R. Sigal,et al.  Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus , 2003, Diabetologia.

[21]  T. Lehtimäki,et al.  Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy. , 2003, Metabolism: clinical and experimental.

[22]  R. Nijveldt,et al.  Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. , 2002, Analytical biochemistry.

[23]  R. Sigal,et al.  Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.

[24]  J P Cooke,et al.  Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. , 2001, The American journal of cardiology.

[25]  D. Sellen,et al.  Genetics of Criminal and Antisocial Behaviour. Ciba Foundation Symposium 194. Pp. 283. Edited by G. R. Bock & J. A. Goode. (Wiley, Chichester, 1996.) £50.00. , 1998, Journal of Biosocial Science.

[26]  S. Moncada,et al.  Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure , 1992, The Lancet.

[27]  A. H. Ismail,et al.  Nomogram by Astrand and Ryhming as a predictor of maximum oxygen intake. , 1966, Journal of applied physiology.